7-ketocholesterol has been researched along with Diabetic Nephropathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ban, N; Imamura, H; Ishihara, N; Kawana, H; Nakamura, S; Ohira, M; Oka, R; Saiki, A; Sato, Y; Shimizu, N; Tanaka, S; Tatsuno, I; Watanabe, Y; Yamaguchi, T | 1 |
| JingZhi, G; Matsui, J; Murakami, H; Suda, T; Tamasawa, N; Yamato, K | 1 |
2 other study(ies) available for 7-ketocholesterol and Diabetic Nephropathies
| Article | Year |
|---|---|
7-Ketocholesterol induces ROS-mediated mRNA expression of 12-lipoxygenase, cyclooxygenase-2 and pro-inflammatory cytokines in human mesangial cells: Potential role in diabetic nephropathy.
Topics: Arachidonate 12-Lipoxygenase; Cell Survival; Cyclooxygenase 2; Diabetic Nephropathies; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Humans; Interleukin-1beta; Interleukin-6; Ketocholesterols; Mesangial Cells; Reactive Oxygen Species; RNA, Messenger | 2018 |
Plasma levels of soluble vascular adhesion molecule-1 and cholesterol oxidation product in type 2 diabetic patients with nephropathy.
Topics: Aged; Case-Control Studies; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glycated Hemoglobin; Humans; Ketocholesterols; Lipids; Male; Middle Aged; Oxidation-Reduction; Vascular Cell Adhesion Molecule-1 | 2001 |